Viewing data from:

DESIPRAMINE HYDROCHLORIDE

ANDA

DESIPRAMINE HYDROCHLORIDE | A071803 | ANI PHARMACEUTICALS INC

5 strengths0 unique patents0 unique exclusivities

API Supply Chain1 active DMF6 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

LUNDBECK PHARMACEUTICALS ITALY SPADESIPRAMINE HYDROCHLORIDE

DMF 33741978

FARCHEMIA SRLInactiveDESIPRAMINE HYDROCHLORIDE USP

DMF 53671984

IRISH FINE CHEMICALS LTDInactiveDESIPRAMINE HYDROCHLORIDE

DMF 66431986

ACF CHEMIEFARMA NVInactiveDESIPRAMINE HYDROCHLORIDE

DMF 66631986

ARCHIMICA SPAInactiveDESIPRAMINE HYDROCHLORIDE USP

DMF 72161987

FABBRICA ITALIANA SINTETICI SPAInactiveDESIPRAMINE HYDROCHLORIDE

DMF 74011988

PCASInactiveDESIPRAMINE HYDROCHLORIDE

DMF 104611993

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (5)

Sort:

#001 — 100MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 29, 1997

No patent or exclusivity listings for this strength.

#002 — 25MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 8, 1987

#003 — 50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 8, 1987

#004 — 75MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 8, 1987

#005 — 150MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: May 29, 1997